Arthur M Krieg

Founder, Chief Strategy Officer

Arthur M Krieg is a skilled expert, working in Checkmate Pharmaceuticals main office of which is in 518. as a Founder, Chief Strategy Officer from 2018. Arthur has earned professional experience in more than eight positions at various companies. Arthur M Krieg went to the Washington University In St. Louis and was studying there from 1979 to 1983. Cambridge, Massachusetts is the area, where this person was lastly known to live. The professional's contacts can be easily accessed through Connexy by request.
Name variants:
Art Krieg, Artie Krieg, Arty Krieg

If it is your profile

Claim it

You may know Arthur M Krieg

Make recommendation

Contact Information

Last Update
Jul 11, 2022
Email
ar**@pfizer.com, ar**@uiowa.edu
Location
Cambridge, MA
Company
Checkmate Pharmaceuticals

Workplace

Founder, Chief Strategy Officer

Work History

Founder, Chief Strategy Officer

245 Main St, Cambridge, MA 02142
from Dec 2018

Chief Executive Officer

245 Main St, Cambridge, MA 02142
CEO at Checkmate Pharmaceuticals
from Dec 2014

Chief Strategy Officer

215 1St St, Cambridge, MA 02142
developer of innovative RNA-based therapeutics
Jan 2014 — Jul 2014

Chief Executive Officer

200 Sidney St SUITE 310, Cambridge, MA 02139
RNA-targeted medicines that selectively activate protein expression
Jun 2011 — Jan 2014

Entrepreneur In Residence

400 Technology Sq, Cambridge, MA 02139
Jun 2011 — Jan 2012

Cso, Vice President

New York, NY
Responsible for Oligonucleotide Therapeutics Site head, Cambridge and Dusseldorf, Germany
2008 — 2011

Founder, Chief Strategy Officer

1997 — 2008

Professor

1 west Prentiss St, Iowa City, IA 52240
1991 — 2001

Education

Occupations

Executive
Founder
Chief Strategy Officer
Chief Executive Officer
Founding Member
Chief Executive
Corporate Executive

Skills

Drug Development
Drug Discovery
Biotechnology
Pharmaceutical Industry
Biopharmaceuticals
Clinical Development
Lifesciences
Molecular Biology
Immunology
Biochemistry
Technology Transfer
In Vivo
Oncology
Clinical Trials
Commercialization
R&D
Infectious Diseases
Cell
Pharmacology
Cancer
Protein Chemistry
Medical Devices
Vaccines
Login